Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders 2013
DOI: 10.1007/978-1-4614-7940-6_5
|View full text |Cite
|
Sign up to set email alerts
|

Cannabinoid Modulation of Dopaminergic Circuits in Neurodegenerative and Neuropsychiatric Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 280 publications
0
1
0
Order By: Relevance
“…Exogenous cannabinoids also appear to affect dopaminergic transmission differently than eCBs. It has shown that cannabinoid agonists increase the spontaneous firing of dopaminergic cells within the VTA through CB1r signaling [69, 70]. In olfactory-bulbectomized rats, which is an animal model of depression, self-administration of WIN 55,212-2 was increased, suggesting that the increase in the CB1r agonist administration could be an attempt to compensate for the decreased DA neurotransmission and rewarding effects observed in some animal models of depression [71].…”
Section: The Endocannabinoid System and Monoaminesmentioning
confidence: 99%
“…Exogenous cannabinoids also appear to affect dopaminergic transmission differently than eCBs. It has shown that cannabinoid agonists increase the spontaneous firing of dopaminergic cells within the VTA through CB1r signaling [69, 70]. In olfactory-bulbectomized rats, which is an animal model of depression, self-administration of WIN 55,212-2 was increased, suggesting that the increase in the CB1r agonist administration could be an attempt to compensate for the decreased DA neurotransmission and rewarding effects observed in some animal models of depression [71].…”
Section: The Endocannabinoid System and Monoaminesmentioning
confidence: 99%